Common Contracts
713 similar Indenture contracts by Akero Therapeutics, Inc., Ambac Financial Group Inc, Kymera Therapeutics, Inc., others
UNICYCIVE THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SUBORDINATED DEBT SECURITIESIndenture • November 13th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE , dated as of [ ● ], among Unicycive Therapeutics, Inc. , a Delaware corporation (the “Company”), and [ TRUSTEE ], as trustee (the “Trustee”):
UNICYCIVE THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SENIOR DEBT SECURITIESIndenture • November 13th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], among Unicycive Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
UNITY SOFTWARE INC. Issuer AND [TRUSTE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • November 8th, 2024 • Unity Software Inc. • Services-prepackaged software • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
INDENTUREIndenture • November 7th, 2024 • Tourmaline Bio, Inc. • Biological products, (no disgnostic substances) • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
INVESCO MORTGAGE CAPITAL INC. and The Bank of New York Mellon, Trustee INDENTURE Dated as of , Providing for Issuance of Subordinated Debt Securities in SeriesIndenture • November 6th, 2024 • Invesco Mortgage Capital Inc. • Real estate investment trusts • New York
THIS INDENTURE between INVESCO MORTGAGE CAPITAL INC., a Maryland corporation (hereinafter called the “Company”) having its principal office at 1331 Spring Street, N.W., Suite 2500, Atlanta, Georgia 30309, and The Bank of New York Mellon, as trustee (hereinafter called the “Trustee”), is made and entered into as of _________________, _______.
KYMERA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt SecuritiesIndenture • October 31st, 2024 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 202[•], among KYMERA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
KYMERA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt SecuritiesIndenture • October 31st, 2024 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 202[•], among KYMERA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
VERA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20 Debt SecuritiesIndenture • October 28th, 2024 • Vera Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20 , among VERA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and[TRUSTEE], as trustee (the “Trustee”):
EUDA HEALTH HOLDINGS LIMITED AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt SecuritiesIndenture • October 18th, 2024 • EUDA Health Holdings LTD • Services-health services • New York
INDENTURE, dated as of , 20__, among EUDA HEALTH HOLDINGS LIMITED, a British Virgin Islands business company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
UBER TECHNOLOGIES, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 9, 2024 Debt SecuritiesIndenture • September 9th, 2024 • Uber Technologies, Inc • Services-business services, nec • New York
Indenture, dated as of September 9, 2024, among Uber Technologies, Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”):
Zura Bio Limited, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • September 3rd, 2024 • Zura Bio LTD • Biological products, (no disgnostic substances) • New York
Indenture, dated as of [·], 20__, among Zura Bio Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), and[Trustee], as trustee (the “Trustee”):
COMPASS THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20_____ Debt SecuritiesIndenture • August 30th, 2024 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS INDENTURE, dated as of [•], 20___, between COMPASS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
SADOT GROUP INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of _______, 20 Debt SecuritiesIndenture • August 29th, 2024 • Sadot Group Inc. • Retail-eating & drinking places • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
BRAINSTORM CELL THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • August 28th, 2024 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [●], 202[●] , among BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
FREEPORT-MCMORAN INC., Company AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION Trustee INDENTURE Dated as of Subordinated Debt SecuritiesIndenture • August 8th, 2024 • Freeport-McMoran Inc • Metal mining • New York
* This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.
REPARE THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • August 6th, 2024 • Repare Therapeutics Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among REPARE THERAPEUTICS INC., a corporation existing under the laws of the province of Québec (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
POSEIDA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • August 5th, 2024 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 20__, among POSEIDA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
Travere Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • August 1st, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among TRAVERE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
AMBAC FINANCIAL GROUP, INC. as Issuer and The Bank of New York Mellon as Trustee INDENTURE DATED AS OF August 1, 2024 Senior Debt SecuritiesIndenture • August 1st, 2024 • Ambac Financial Group Inc • Surety insurance • New York
INDENTURE, dated as of August 1, 2024, between Ambac Financial Group, Inc., a Delaware corporation (the “Company”), having its principal office at One World Trade Center, New York, New York 10007, and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”).
AMBAC FINANCIAL GROUP, INC. as Issuer and The Bank of New York Mellon as Trustee INDENTURE DATED AS OF August 1, 2024 Subordinated Debt SecuritiesIndenture • August 1st, 2024 • Ambac Financial Group Inc • Surety insurance • New York
INDENTURE, dated as of August 1, 2024, between Ambac Financial Group, Inc., a Delaware corporation (the “Company”), having its principal office at One World Trade Center, New York, New York 10007, and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”).
LAKELAND INDUSTRIES, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ___________, 20__ Debt SecuritiesIndenture • July 12th, 2024 • Lakeland Industries Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
INDENTURE, dated as of __________, 20__, among LAKELAND INDUSTRIES, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
TRINITY BIOTECH PLC Issuer AND [TRUSTEE], TrusteeIndenture • June 28th, 2024 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of , 20 , among Trinity Biotech PLC, a public limited company incorporated under the laws of Ireland (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
DELCATH SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [], 20__ Debt SecuritiesIndenture • June 28th, 2024 • Delcath Systems, Inc. • Surgical & medical instruments & apparatus • New York
Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
MULTIMETAVERSE HOLDINGS LIMITED Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt SecuritiesIndenture • June 18th, 2024 • MultiMetaVerse Holdings LTD • Services-prepackaged software • New York
INDENTURE, dated as of , 20 , among MultiMetaVerse Holdings Limited, a British Virgin Islands business company (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
ABEONA THERAPEUTICS INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ___________, 20 Debt SecuritiesIndenture • June 12th, 2024 • Abeona Therapeutics Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of _____, 20 ____, among Abeona Therapeutics Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
VERITONE, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ___________, 20__ Debt SecuritiesIndenture • June 12th, 2024 • Veritone, Inc. • Services-computer processing & data preparation • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
AEROVATE THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 202[·] Subordinated Debt SecuritiesIndenture • June 10th, 2024 • Aerovate Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 202 , among AEROVATE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
SEMLER SCIENTIFIC, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 202[·] Senior Debt SecuritiesIndenture • June 6th, 2024 • Semler Scientific, Inc. • Electromedical & electrotherapeutic apparatus • New York
INDENTURE, dated as of [·], 202[·] , among SEMLER SCIENTIFIC, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
SEMLER SCIENTIFIC, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 202[●] Subordinated Debt SecuritiesIndenture • June 6th, 2024 • Semler Scientific, Inc. • Electromedical & electrotherapeutic apparatus • New York
INDENTURE, dated as of [●], 202[●] , among SEMLER SCIENTIFIC, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
ZEVRA THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • June 4th, 2024 • Zevra Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among Zevra Therapeutics, Inc., a Delaware corporation (the “Company”), and[TRUSTEE], as trustee (the “Trustee”):
SUNCAR TECHNOLOGY GROUP INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • June 3rd, 2024 • SunCar Technology Group Inc. • Services-automotive repair, services & parking • New York
Indenture, dated as of [●], 20__, among SunCar Technology Group Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), and [Trustee], as trustee (the “Trustee”):
CERTAIN SECTIONS OF THIS INDENTURE RELATING TO SECTIONS 310 THROUGH 318, INCLUSIVE, OF THE TRUST INDENTURE ACT OF 1939:Indenture • May 21st, 2024 • NMI Holdings, Inc. • Surety insurance
INDENTURE (herein called this “Indenture”), dated as of May 21, 2024, between NMI Holdings, Inc., a corporation duly formed and existing under the laws of the State of Delaware (herein called the “Company”) and The Bank of New York Mellon Trust Company, N.A., as trustee (herein called the “Trustee”).
AKERO THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt SecuritiesIndenture • May 10th, 2024 • Akero Therapeutics, Inc. • Pharmaceutical preparations • New York
SIMILARWEB LTD., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt SecuritiesIndenture • May 10th, 2024 • Similarweb Ltd. • Services-computer programming, data processing, etc. • New York
Indenture, dated as of [·], 20__, among Similarweb Ltd., a company organized under the laws of the State of Israel (the “Company”), and [Trustee], as trustee (the “Trustee”):
AKERO THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt SecuritiesIndenture • May 10th, 2024 • Akero Therapeutics, Inc. • Pharmaceutical preparations • New York
